BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37477143)

  • 1. Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).
    Zhang B; Yang L; He Y; Han D; Qi P; Shang P
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of noncoding RNAs in metabolic reprogramming of cancer cells.
    Safi A; Saberiyan M; Sanaei MJ; Adelian S; Davarani Asl F; Zeinaly M; Shamsi M; Ahmadi R
    Cell Mol Biol Lett; 2023 May; 28(1):37. PubMed ID: 37161350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.
    Kansara S; Singh A; Badal AK; Rani R; Baligar P; Garg M; Pandey AK
    Semin Cancer Biol; 2023 Oct; 95():1-12. PubMed ID: 37364663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
    Li J; Lu Z; Zhang Y; Xia L; Su Z
    Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
    He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
    Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
    Sanya DRA; Onésime D
    Hum Cell; 2023 Jul; 36(4):1343-1372. PubMed ID: 37209205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.
    Xu S; Wang L; Zhao Y; Mo T; Wang B; Lin J; Yang H
    J Biomed Sci; 2024 Feb; 31(1):25. PubMed ID: 38408962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
    Chen C; Shang A; Sun Z; Gao Y; Huang J; Ping Y; Chang W; Gu C; Sun J; Ji P; Yuan Y; Lu R; Li D
    J Immunol Res; 2022; 2022():9038808. PubMed ID: 35127956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
    Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
    Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of the immune microenvironment-related non-coding RNA IGF2BP2-AS1 in bladder cancer.
    Ding K; Zheng Z; Han Y; Huang X
    Cell Cycle; 2022 Dec; 21(23):2533-2549. PubMed ID: 35894701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.
    Abedi-Gaballu F; Kamal Kazemi E; Salehzadeh SA; Mansoori B; Eslami F; Emami A; Dehghan G; Baradaran B; Mansoori B; Cho WC
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNA in cancer.
    Yan H; Bu P
    Essays Biochem; 2021 Oct; 65(4):625-639. PubMed ID: 33860799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
    Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
    Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9814-9820. PubMed ID: 31799648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in Cancer Progression: Role of Noncoding RNAs.
    Zuo YB; Zhang YF; Zhang R; Tian JW; Lv XB; Li R; Li SP; Cheng MD; Shan J; Zhao Z; Xin H
    Int J Biol Sci; 2022; 18(5):1829-1843. PubMed ID: 35342359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming.
    Yang D; Sun L; Li Z; Gao P
    Adv Exp Med Biol; 2016; 927():191-215. PubMed ID: 27376736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.